Advancements in macrophage research for cardiovascular disease

Meiling Cao1, Yu Sun2, Xinyue Zhang2,3

  • 1Department of Neonatology, The First Hospital of China Medical University, Shenyang, China.

Frontiers in Physiology
|September 2, 2025
PubMed

Insights

Macrophages are key immune cells in cardiovascular disease pathogenesis. Understanding their diverse roles and metabolic functions offers potential new therapeutic strategies for conditions like atherosclerosis and hypertension.

Area of Science:

  • Immunology
  • Cardiology
  • Cell Biology

Background:

  • Cardiovascular diseases (CVDs) represent a significant global health burden, driving the need for deeper insights into disease mechanisms.
  • Macrophages, central to innate immunity, are increasingly recognized for their complex roles in CVD pathogenesis.
  • Understanding macrophage heterogeneity and function is crucial for developing effective CVD treatments.

Purpose of the Study:

  • To provide a comprehensive overview of macrophage subpopulations, heterogeneity, and ontogeny.
  • To elucidate the influence of cellular metabolism on macrophage functions in the cardiovascular system.
  • To explore macrophage roles in specific cardiovascular diseases and their therapeutic potential.

Main Methods:

  • Literature review focusing on macrophage biology and cardiovascular disease.
  • Analysis of current research on macrophage subpopulations and their functional diversity.
  • Examination of metabolic pathways impacting macrophage behavior.

Main Results:

  • Macrophages exhibit significant heterogeneity and diverse ontogenetic origins.
  • Cellular metabolism profoundly impacts macrophage functions, influencing their pro- or anti-inflammatory states.
  • Macrophages are implicated in the pathogenesis of atherosclerosis, hypertension, and myocardial infarction.

Conclusions:

  • Targeting cardiac macrophages and their metabolic processes presents a promising therapeutic avenue for cardiovascular diseases.
  • Further research is needed to overcome current limitations and refine therapeutic strategies involving cardiac macrophages.